564 results on '"Gattaz, Wagner F"'
Search Results
2. Lithium increases cortical and subcortical volumes in subjects with bipolar disorder
3. Phospholipase A2 expression in prostate cancer as a biomarker of good prognosis: A comprehensive study in patients with long follow-up.
4. Increased PLA2 activity in individuals at ultra-high risk for psychosis
5. Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial
6. Genetic polymorphisms of the serotonin transporter are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis
7. Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial
8. Differences in the immune-inflammatory profiles of unipolar and bipolar depression
9. Reduced Annexin A3 in schizophrenia
10. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study
11. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression
12. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis
13. Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice
14. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer’s disease patients
15. Kynurenine is correlated with IL-1β in plasma of schizophrenia patients
16. Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia
17. A Longitudinal (6-week) 3T 1H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression
18. Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
19. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder
20. Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes
21. Hippocampal serotonin depletion is related to the presence of generalized tonic–clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy
22. Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium
23. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis
24. Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes
25. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial
26. Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder
27. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium
28. Leukocyte mitochondrial DNA copy number in bipolar disorder
29. Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial
30. Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer’s disease
31. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
32. Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers
33. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study
34. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis
35. Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania
36. Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder.
37. Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue
38. Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus
39. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes
40. Reduced serum levels of adiponectin in elderly patients with major depression
41. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
42. Circulating Glial-derived neurotrophic factor is reduced in late-life depression
43. Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism
44. Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways
45. Increased PLA 2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis
46. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer’s disease
47. Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus
48. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
49. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
50. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimerʼs disease pathological signature in the cerebrospinal fluid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.